Assessment of a Novel Fixed-dose Combination (FDC) Drug VR-AD-1005 for the Treatment of Acute Watery Diarrhea in Cholera
- First Posted Date
- 2024-01-05
- Last Posted Date
- 2024-02-28
- Lead Sponsor
- Hunazine Biotech S.L.
- Target Recruit Count
- 150
- Registration Number
- NCT06193408
- Locations
- 🇧🇩
Icddr,b, Dhaka, Bangladesh
© Copyright 2025. All Rights Reserved by MedPath